Dermatology

This site is intended for healthcare professionals only

Login Register

MD Brand Connect
Webinars
Vaccine Hub
MDTV
Fact Check
Health Dialogues

Medical News & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry
MDTV

This site is intended for healthcare professionals only

Login Register

LoginRegister

Home
Medical news & Guidelines
Health news
Fact Check
AYUSH
State News
Medical Education
Industry

Ruchika Sharma

Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home

Ruchika Sharma

Articles By : Ruchika Sharma

Discussion between Govt, US manufacturers for procuring COVID vaccines not yet over: NTAGI Chief

Ruchika Sharma3 Aug 2021 10:30 AM IST

New Delhi: Discussions and negotiations are still not over between the government and US-based COVID-19 vaccine manufacturers for procuring their...

5 pharma firms tapping IPO market to raise over Rs 8000 crore

Ruchika Sharma3 Aug 2021 10:00 AM IST

Mumbai: Riding on huge investor interest in the healthcare sector, five pharma companies are tapping the initial public offering (IPO) market over the...

Still in talks with Indian govt on COVID vaccine: Johnson and Johnson

Ruchika Sharma2 Aug 2021 5:56 PM IST

Bengaluru: Johnson & Johnson said on Monday it was still in talks with the Indian government over its COVID-19 vaccine after the country's...

Glenmark, SaNOtize collaborate to commercialize Nitric Oxide Nasal Spray for COVID-19 in Asian markets

Ruchika Sharma2 Aug 2021 2:54 PM IST

Nitric Oxide Nasal Spray is one of the few novel therapeutic treatments, outside of expensive monoclonal antibodies, that is proven to reduce...

Janssen Pharma Selexipag gets USFDA nod to treat pulmonary arterial hypertension

Ruchika Sharma2 Aug 2021 12:15 PM IST

Titusville: The Janssen Pharmaceutical Companies of Johnson & Johnson recently announced that the U.S. Food and Drug Administration (FDA) has...

Serum Institute, CII to work together for expansion of COVID vaccination in small towns, rural areas

Ruchika Sharma2 Aug 2021 11:00 AM IST

"Our partnership with CII will be a good way to close the gaps, as there is plenty of supply of Covishield available for distribution," Poonawalla...

Sputnik V production to go fully on stream in September in India, says RDIF

Ruchika Sharma2 Aug 2021 10:00 AM IST

New Delhi: The production of Russia's coronavirus vaccine Sputnik V in India is expected to come fully on stream in September, the Russian Direct...

More than 8000 pharma units present in States, UTs, Minister informs Parliament

Ruchika Sharma1 Aug 2021 9:15 AM IST

New Delhi: Over 8000 pharma units are present in States and Union Territories (UTs) across the nation, the Minister of Chemical and Fertilizer Mansukh...

Shilpa Medicare gets WHO-Geneva nod for API Praziquental to treat blood, liver fluke

Ruchika Sharma31 July 2021 10:00 AM IST

Bengaluru: Shilpa Medicare Limited has recently announced that the company has received confirmation from WHO-Geneva for prequalification of Active...

FIRST: Roche launches Spinal Muscular Atrophy treatment Evrysdi in India

Ruchika Sharma30 July 2021 1:30 PM IST

Mumbai: Roche has announced the launch of Evrysdi (risdiplam), the first and only approved treatment in India for Spinal Muscular Atrophy (SMA)...

Brazil shelves import authorisation of Bharat Biotech Covaxin

Ruchika Sharma30 July 2021 12:44 PM IST

New Delhi: After suspending the proposed clinical trials of Bharat Biotech's COVID-19 vaccine Covaxin and a request for Emergency Use...

Shilpa Medicare gets WHO-Geneva nod for API, Tenofovir Disoproxil Fumarate for HIV, Hepatitis B

Ruchika Sharma30 July 2021 12:00 PM IST

Karnataka: Shilpa Medicare Limited has recently announced the receipt of confirmation of WHO - GENEVA approval for API, Tenofovir Disoproxil...

Powered By: Hocalwire

X

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok